Alere Inc. Schedules Conference Call for 8:30 a.m. ET October 29, 2013 to Discuss Third Quarter 2013 Results

  Alere Inc. Schedules Conference Call for 8:30 a.m. ET October 29, 2013 to
                      Discuss Third Quarter 2013 Results

PR Newswire

WALTHAM, Mass., Oct. 22, 2013

WALTHAM, Mass., Oct. 22, 2013 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global
leader in enabling individuals to take charge of their health at home through
the merger of rapid diagnostics and health information solutions, today
announced that it will release its third quarter 2013 earnings on Tuesday,
October 29, 2013. The Company will also host a conference call beginning at
8:30 a.m. (Eastern Time) on that date to discuss these results and other
corporate matters. During the conference call, the Company will discuss and
answer questions concerning business and financial developments and trends.
The Company's responses to questions, as well as other matters discussed
during the conference call, may contain or constitute information that has not
been disclosed previously.

The conference call may be accessed by dialing (877) 270-2148 (domestic) or
(412) 902-6510 (international) and asking for Alere Inc.A webcast of the call
can also be accessed via the Alere website at www.alere.com/investors, or
directly through the following link: http://www.videonewswire.com/event.

A replay will be available approximately one hour after the conclusion of the
call and will remain available for a period of seven days following the call.
The replay may be accessed by dialing (877) 344-7529 (domestic) or (412)
317-0088 (international) and entering replay code 10036058. The replay will
also be available via online webcast at http://www.videonewswire.com/event or
via the Alere website at www.alere.com/investors for a period of 60 days
following the call.

By developing new capabilities in near-patient diagnosis, monitoring and
health information solutions, Alere enables individuals to take charge of
improving their health and quality of life at home. Alere's global leading
products and services, as well as its new product development efforts, focus
on cardiology, infectious disease, toxicology and diabetes.Alere is
headquartered in Waltham, Massachusetts.

For additional information on Alere, please visit www.alere.com.

SOURCE Alere Inc.

Website: http://www.alere.com
Contact: Doug Guarino, 781-647-3900
 
Press spacebar to pause and continue. Press esc to stop.